Published in J Gastroenterol on July 31, 2012
Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol (2014) 0.90
Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol (2013) 0.90
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol (2015) 0.84
Resection of a cholangiocarcinoma via laparoscopic hepatopancreato- duodenectomy: a case report. World J Gastroenterol (2014) 0.81
Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.79
Clinicopathological significance of mucin production in patients with papillary cholangiocarcinoma. World J Surg (2015) 0.78
Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol (2015) 0.76
Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction. J Gastrointest Surg (2016) 0.75
Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series. Surg Endosc (2016) 0.75
Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection. Langenbecks Arch Surg (2016) 0.75
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med (1965) 4.22
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Management strategies in resection for hilar cholangiocarcinoma. Ann Surg (1992) 3.69
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
New staging system and a registry for perihilar cholangiocarcinoma. Hepatology (2011) 2.89
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg (1990) 2.86
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer (2010) 2.82
Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2011) 2.51
Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol (2004) 2.39
Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg (2010) 2.34
Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol (2011) 2.11
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03
Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc (2007) 2.02
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99
Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol (2010) 1.98
Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg (2013) 1.91
The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg (1998) 1.90
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg (2012) 1.73
Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg (1986) 1.72
Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology (1991) 1.69
Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg (2010) 1.69
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol (2005) 1.64
Preoperative portal vein embolization: an audit of 84 patients. Hepatology (1999) 1.64
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer (2004) 1.62
Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer (2004) 1.58
Liver transplantation for cholangiocarcinoma. Transpl Int (2010) 1.58
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery (2007) 1.54
Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg (1991) 1.54
Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery (1995) 1.52
Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg (2010) 1.51
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer (1977) 1.49
Percutaneous transhepatic cholangial drainage: direct approach under fluoroscopic control. J Surg Oncol (1976) 1.48
Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology (1996) 1.47
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology (2001) 1.45
Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Sci (2009) 1.44
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci (2009) 1.44
Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology (1995) 1.43
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy (1993) 1.43
Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc (2005) 1.41
"Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg (2006) 1.39
Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci (2009) 1.38
Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg (2000) 1.37
Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg (2012) 1.37
Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35
Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery (2000) 1.34
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol (2009) 1.32
Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery (1996) 1.30
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol (2008) 1.28
Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc (2002) 1.26
Percutaneous transhepatic biliary drainage in patients with malignant biliary obstruction of the hepatic confluence. Hepatogastroenterology (1992) 1.25
Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol (2011) 1.24
Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg (2006) 1.24
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2007) 1.20
Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology (2006) 1.20
Technique of inserting multiple biliary drains and management. Hepatogastroenterology (1996) 1.19
Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc (2002) 1.18
Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg (2009) 1.15
Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol (2000) 1.14
Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol (2010) 1.12
Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract. Br J Surg (1994) 1.10
Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci (2009) 1.09
Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg (2009) 1.09
Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol (2007) 1.09
Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg (2010) 1.06
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging (2002) 1.06
Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. AJR Am J Roentgenol (1998) 1.05
Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2009) 1.05
Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg (2007) 1.03
Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg (2012) 1.02
Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg (2013) 1.02
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02
Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2009) 1.01
Value of percutaneous transhepatic cholangioscopy (PTCS). Surg Endosc (1988) 1.00
Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg (2003) 0.99
Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci (2009) 0.99
Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg (2009) 0.98
Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol (2010) 0.97
Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg (2002) 0.97
Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg (2011) 0.96
High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg (2007) 0.96
Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy? J Hepatobiliary Pancreat Surg (2007) 0.95
Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg (2008) 0.95